Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations

Autor: Kaparou, Maria, Rudzki, Zbigniew, Giles, Hannah, Murthy, Vidhya, Srinath, Swathy, Lloyd, Rebecca, Ahmed, Maria Zahid, Salhan, Beena, Chauhan, Saleena, Kishore, Bhuvan, Lovell, Richard, Horgan, Claire, Paneesha, Shankara, Xenou, Evgenia, Lokare, Anand, Ewing, Joanne, Dassanayake, Hansini, Nikolousis, Emmanouil, Kanellopoulos, Alexandros
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Case Reports in Hematology.
ISSN: 2090-6560
DOI: 10.1155/2021/8843063
Popis: The present study describes a patient aged 70 with very high-risk AML who successfully received a nonmyeloablative matched unrelated donor allograft shortly following SARS-CoV-2 infection, which manifested with mild cough, interstitial abnormalities on chest CT, and pancytopenia with profound bone marrow biopsy histological alterations. In parallel, our study provides bone marrow biopsy data in a series of contemporary patients with serious haematological diseases who had a bone marrow biopsy performed within two weeks of PCR confirmation of SARS-CoV-2 infection. This study is notable because there are no published data describing the bone marrow biopsy changes observed in patients with haematological malignancies and SARS-CoV-2 infection. Finally, it is suggested that nonmyeloablative hematopoietic stem cell transplantation for very high-risk haematological malignancies can be successfully performed following recovery from SARS-CoV-2 infection.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje